Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix-Reference-Cited by-同舟云学术

Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix

Published:2009-07 Issue:7 Volume:13 Page:1291-1301
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:

Author:

Willems Stefan M.,Mohseny Alex B.,Balog Crina,Sewrajsing Raj,Briaire-de Bruijn Inge H.,Knijnenburg Jeroen,Cleton-Jansen Anne-Marie,Sciot Raf,Fletcher Christopher D. M.,Deelder André M.,Szuhai Karoly,Hensbergen Paul J.,Hogendoorn Pancras C. W.

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1582-4934.2009.00747.x/fullpdf

Reference46 articles.

1. Myxoid tumours of soft tissue;Graadt van Roggen;Histopathology.,1999

2. Cellular myxoma: a clinicopathologic study of 38 cases confirming indolent clinical behavior;Graadt van Roggen;Mod Pathol.,2001

3. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant;Mentzel;Am J Surg Pathol.,1996

4. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis;Meis-Kindblom;Virchows Arch.,2001

5. Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model;Willems;Mod Pathol.,2006

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Methylation Analysis in Distinguishing Cellular Myxoma from Low-Grade Myxofibrosarcoma;International Journal of Molecular Sciences;2024-05-08

2. Oral myxofibrosarcoma: A comprehensive case report;Oral Oncology Reports;2024-03

3. A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models;BMC Cancer;2023-12-06

4. Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?;Cancers;2023-10-25

5. Multi-modality classification between myxofibrosarcoma and myxoma using radiomics and machine learning models;Medical Imaging 2022: Computer-Aided Diagnosis;2022-04-04